Previous 10 | Next 10 |
HOUSTON , March 20, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ann...
HOUSTON , March 11, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today ann...
HOUSTON , March 9, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
Today, we will see why Soliton ( SOLY ) is a promising pick for 2020. Company overview Soliton, Inc. is a pre-revenue stage medical device company focused on the development and commercialization of innovative products for removing unwanted tattoos. The company's proprietary RAP (Rapid...
February 11, 2020 Palm Beach, FL – February 11, 202- There is no doubt that the global medical device market has been showing outstanding growth for the last few years and that it will continue to do so in the near future… and most likely beyond then. It also should see ...
HOUSTON , Feb. 11, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
HOUSTON , Feb. 6, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today an...
HOUSTON , Jan. 27, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
Editor's note: Seeking Alpha is proud to welcome Marvl Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » CellFX, a Pulse Bi...
HOUSTON , Jan. 13, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...
News, Short Squeeze, Breakout and More Instantly...
Allergan Aesthetics Completes Acquisition of Soliton -- Addition of Soliton complements Body Contouring Portfolio with expansion to treat appearance of cellulite -- PR Newswire IRVINE, Calif. , Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie comp...
On a gloomy day for the stock market, healthcare aesthetics specialist Soliton (NASDAQ: SOLY) was a luminous bright spot on Tuesday. The company's shares rocketed almost 12% higher, on news that its absorption into soon-to-be-parent AbbVie (NYSE: ABBV) is about to close. ...
Soliton Inc. (NASDAQ:SOLY) traded today at a new 52-week high of $22.60. So far today approximately 147,000 shares have been exchanged, as compared to an average 30-day volume of 103,000 shares. Based on a current price of $22.53, Soliton Inc. is currently 19.0% above its average consens...